<?xml version="1.0" encoding="UTF-8"?>
<p id="p0220">Taken together, several emerging technologies are now available to design and assess the efficacy and activity of novel M2 inhibitors. However, it is important to note that both TEVC and PRA remain “gold standards” for these studies and should be applied as secondary assays to rule out false positives obtained from higher-throughput methods.</p>
